Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages: Role of Mcl-1, Independent of Nuclear Factor (Nf)-κb, Bad, or Caspase Activation by Liu, Hongtao et al.
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2001/07/113/13 $5.00
Volume 194, Number 2, July 16, 2001 113–125
http://www.jem.org/cgi/content/full/194/2/113
 
113
 
Constitutively Activated Akt-1 Is Vital for the Survival of 
Human Monocyte-differentiated Macrophages: 
 
Role of Mcl-1, Independent of Nuclear Factor (NF)-
 
 
 
B, 
Bad, or Caspase Activation
 
Hongtao Liu, Harris Perlman, Lisa J. Pagliari,
 
 
 
and Richard M. Pope
 
Division of Rheumatology, Department of Medicine, Northwestern University Medical School, 
and the VA Chicago Health Care System, Lakeside Division, Chicago, IL 60611
 
Abstract
 
Recent data from mice deficient for phosphatase and tensin homologue deleted from chromo-
 
some 10 or src homology 2 domain–containing 5
 
 
 
 inositol phosphatase, phosphatases that nega-
tively regulate the phosphatidylinositol 3-kinase (PI3K) pathway, revealed an increased number
of macrophages in these animals, suggesting an essential role for the PI3K pathway for macro-
phage survival. Here, we focused on the role of the PI3K-regulated serine/threonine kinase
Akt-1 in modulating macrophage survival. Akt-1 was constitutively activated in human mac-
rophages and addition of the PI3K inhibitor, LY294002, suppressed the activation of Akt-1 and
induced cell death. Furthermore, suppression of Akt-1 by inhibition of PI3K or a dominant neg-
ative (DN) Akt-1 resulted in loss of mitochondrial transmembrane potential, activation of
caspases-9 and -3, and DNA fragmentation. The effects of PI3K inhibition were reversed by the
 
ectopic expression of constitutively activated Akt-1 or Bcl-x
 
L
 
. Inhibition of PI3K/Akt-1 path-
way either by LY294002 or DN Akt-1 had no effect on the constitutive or inducible activation
of nuclear factor (NF)-
 
 
 
B in human macrophages. However, after inhibition of the PI3K/Akt-1
 
pathway, a marked decrease in the expression of the antiapoptotic molecule Mcl-1, but not other
Bcl-2 family members was observed, and Mcl-1 rescued macrophages from LY294002-induced cell
death. Further, inhibition of Mcl-1 by antisense oligonucleotides, also resulted in macrophage
apoptosis. Thus, our findings demonstrate that the constitutive activation of Akt-1 regulates
macrophage survival through Mcl-1, which is independent of caspases, NF-
 
 
 
B, or Bad.
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Introduction
 
Macrophages are critical in the pathogenesis of diseases
 
such as rheumatoid arthritis (1), atherosclerosis and Crohn’s
disease (2). Unlike monocytes, macrophages are long-lived
 
cells, resistant to many apoptotic stimuli including Fas
 
and TNF-
 
 
 
 death receptor ligation, ionizing radiation,
and multiple antineoplastic or cytotoxic agents (3). We re-
cently demonstrated that expression of Fas-associated
death domain–like IL-1
 
 
 
–converting enzyme–inhibitory
protein protected differentiated macrophages from Fas-
mediated apoptosis (3) and that constitutively activated
 
nuclear factor (NF)
 
*
 
-
 
 
 
B is essential for the expression
of A1/Bfl-1, mitochondrial homeostasis and macrophage
survival (4). However, other mechanisms that may
uniquely contribute to macrophage survival have not been
fully elucidated.
 
Apoptosis may be initiated by ligation of specific death
 
receptors, such as Fas or TNFR1. Death receptor signal-
 
ing activates caspase-8 (5), which is capable of cleav-
ing caspase-3. In certain cell types, caspase-8 activation may
directly induce loss of mitochondrial transmembrane po-
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*
 
Abbreviations used in this paper:
 
 
 
  
 
m
 
, mitochondrial transmembrane po-
tential; Ad, adenovirus; AIF, apoptosis-inducing factor; DN, dominant
negative; EMSA, electrophoretic mobility shift assay; GFP, green fluores-
cence protein; INV, inverted antisense oligonucleotides; moi, multiplicity
of infection; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide; NF, nuclear factor; NIK, NF-
 
 
 
B–inducing kinase; PI, propid-
ium iodide; PI3K, phosphatidylinositol 3-kinase; PTEN, phosphatase and
tensin homologue deleted from chromosome 10. 
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tential (
 
  
 
m
 
) through activation of Bid (6). Alternatively,
apoptosis may be initiated at the mitochondria by disrup-
tion of 
 
  
 
m
 
, and release of cytochrome c into the cytosol
(7). Mitochondria integrity is regulated by the Bcl-2 family
of proteins, which includes both antiapoptotic (e.g., Bcl-2,
Bcl-x
 
L
 
, and A1/Bfl-1; reference 8) and proapoptotic (e.g.,
Bax, Bik, Bak, Bad, and Bid; reference 7) family members.
Mice deficient in either src homology 2 domain–con-
taining 5
 
 
 
 inositol phosphatase or phosphatase and tensin
homologue deleted from chromosome 10 (PTEN) possess
increased numbers of macrophages (9, 10). Both of these
phosphatases normally function to suppress the phosphati-
dylinositol 3-kinase (PI3K) pathway (11, 12), suggesting
that this pathway is critical for macrophage survival. The
serine/threonine kinase Akt-1 is a major target of PI3K
(13), which may be activated by a wide variety of stimuli
including cytokines, chemokines, growth and survival fac-
tors, and integrin ligation (14, 15). Activation of the PI3K/
Akt-1 pathway protects against cell death induced by a va-
riety of apoptotic stimuli. Although the mechanisms re-
sponsible for protection have not been fully elucidated, the
phosphorylation Bad or caspase-9, suppression of FasL ex-
pression, and NF-
 
 
 
B activation may be induced through
the PI3K/Akt-1 pathway (16–22). Although a prior study
demonstrated that inhibition of the PI3K pathway resulted
in apoptosis of murine peritoneal macrophages (15), the
mechanism by which the PI3K/Akt-1 pathway promotes
macrophage survival is not known.
In this study, we investigated the role of Akt-1 in the
survival of primary human monocyte-differentiated macro-
phages. We observed that Akt-1 was constitutively ex-
pressed and activated in human macrophages. Inhibition of
Akt-1 activation resulted in macrophage apoptosis medi-
ated through the loss of 
 
  
 
m
 
 and the activation of
caspases-9 and -3. Activated Akt-1 did not contribute to
activation of NF-
 
 
 
B in macrophages. Additionally, the in-
hibition of the Akt-1 had no effect on the expression of Fas
or FasL, nor the expression or phosphorylation of Bad. In
contrast, inhibition of PI3K/Akt-1 was associated with de-
creased Mcl-1 expression, while other anti- or proapop-
totic Bcl-2 proteins were not altered. These observations
demonstrate that constitutively activated PI3K resulted in
activation of Akt-1 and the expression of Mcl-1, which
were essential for macrophage survival.
 
Materials and Methods
 
Materials.
 
Trypan blue, LY294002, and polymyxin B sulfate
were from Sigma-Aldrich. Lipofectamine was from GIBCO
BRL. Propidium iodide (PI) was from Roche Molecular Bio-
chemicals and rhodamine 123 (Rh123) was from Molecular Probes.
The caspase inhibitors and substrate, zVAD.fmk, zLEHD.fmk,
and Ac-LEVD-AFC, were obtained from Enzyme System Products.
 
Cell Isolation and Culture.
 
Human monocytes were isolated
by countercurrent elutriation from commercially obtained buffy
coats as described previously (4). Monocytes were differentiated
in vitro for 7 d in RPMI 1640 containing 20% heat-inactivated
FBS and 1 
 
 
 
g/ml polymyxin B sulfate. RAW 264.7 cells were
 
obtained from American Type Culture Collection and cultured
in DMEM with 10% heat-inactivated FBS.
 
Adenovirus Infection of Human Macrophages.
 
Differentiated mac-
rophages were infected for 2 h in serum-free RPMI 1640 at the
indicated multiplicity of infection (moi) with replication-defec-
tive adenoviruses (Ads) expressing either 
 
 
 
-galactosidase (Ad-
 
 
 
gal), green fluorescence protein (AdGFP), dominant negative
(DN) Akt-1 (AdDNAkt-1), activated Akt-1 (AdMyrAkt-1), or
Bcl-x
 
L
 
 (AdBcl-x
 
L
 
) as described previously (4).
 
Electrophoretic Mobility Shift Assay.
 
Nuclear extracts were pre-
pared as described previously (23) from macrophages incubated in
control medium or medium containing 50 
 
 
 
m LY294002 or in-
fected with either AdGFP or AdDNAkt-1 for the times indicated
in the figures. An oligonucleotide spanning the 
 
 
 
B binding sites
of HIV/Ig, previously shown to detect NF-
 
 
 
B binding, was em-
ployed for the electrophoretic mobility shift assay (EMSA) as de-
scribed previously (23).
 
Promoter Activity Assay.
 
RAW 264.7 cells were transiently
transfected using lipofectamine with 1 
 
 
 
g of the 3x
 
 
 
B promoter-
reporter plasmid (4) plus 1 
 
 
 
g of a plasmid-expressing constitu-
tively active Akt-1 or a control plasmid, with or without 1 
 
 
 
g of
a plasmid-expressing NF-
 
 
 
B p65. Promoter activity is presented
as relative light units (RLUs) normalized for protein concentra-
tion (RLU per 
 
 
 
g protein).
 
Viability Assays.
 
PI exclusion and 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium (MTT) cleavage were employed to
assess macrophage viability. PI was added just before analysis by
flow cytometry and the data are presented as the percentage of
cell death (PI
 
 
 
 cells) in each culture. MTT assays were performed
as instructed by the supplier and values were calculated relative to
control cultures. Additionally, transient cotransfections were em-
ployed to determine if expression of Mcl-1 could rescue RAW
264.7 cells from death induced by LY294002 treatment. RAW
264.7 cells were cotransfected with 0.5 
 
 
 
g of CMV-EGFP ex-
pression plasmid plus 2.5 
 
 
 
g of plasmids pCI-neo or pCI-Mcl-1.
After transfection, cultures were incubated for 24 h and then
were treated with 50 
 
 
 
M LY294002 for an additional 24 h.
RAW 264.7 cells were collected and GFP-expressing cells were
quantified by flow cytometry.
 
Mcl-1 Antisense.
 
Mcl-1 phosphorothioate antisense oligonu-
cleotides to Mcl-1 (AS) and control inverted antisense oligonucle-
otides (INV) were synthesized by Intergrated DNA Technology,
Inc. The sequences employed were described previously as Mcl-
AS-8 and MclinvAS-8 (24). Primary macrophages were incubated
with either Mcl-1 AS or INV (100 
 
 
 
M) for 24 h, then harvested,
and examined for Mcl-1 expression by Western blot analysis and
apoptosis by determination of subdiploid DNA content.
 
Determination of Subdiploid DNA Content.
 
At the indicated time
points, cultures were stained with PI as described previously (25).
The subdiploid DNA peak (
 
 
 
2N DNA), immediately adjacent
to the G0/G1 peak (2N DNA), represents apoptotic cells and was
quantified by histogram analyses.
 
Determination of Mitochondrial Permeability Transition.
 
Mitochon-
drial dysfunction was assessed using the cationic lipophilic green
fluorochrome rhodamine 123 as described previously (3, 4).
Mean fluorescence was recorded for each sample, and control
cultures at each time point were designated as 100% fluorescence.
 
Western Blot Analysis.
 
Western blot analysis was conducted as
described previously (4) using the indicated antibodies: rabbit
anti–phospho-Akt-1 or total Akt-1 (New England Biolabs); rab-
bit anti–caspase-9 (Calbiochem); rabbit anti-PKC
 
 
 
; rabbit anti–
Mcl-1 (Santa Cruz Biotechnology, Inc.); mouse anti–caspase-3;
mouse anti-Bcl-2; rabbit anti-Bcl-x
 
L
 
; mouse anti-Bax (Transduc- 
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tion Laboratories); rabbit anti-Bad; and phospho-Bad (Cell Sig-
naling Technology), or mouse anti-tubulin (Calbiochem). For
immunoprecipitation of Bad and phospho-Bad, 600 
 
 
 
g extracts
were incubated with 2 
 
 
 
g rabbit anti-Bad and 50 
 
 
 
l of protein A
Sepharose beads (Boehringer) overnight at 4
 
 
 
C. The immuno-
precipitated complexes were electrophoresed on two separate
gels and transferred to membranes which were used for Western
blotting using rabbit anti-Bad and phospho-Bad, respectively. To
examine cytochrome c, cells were suspended in lysis buffer and
incubated for 3 min on ice, as described previously by us (26).
Lysates were homogenized for 1 min and centrifuged for 15 min
(750
 
 
 
 
 
g
 
), and supernatants containing the cytosolic fraction were
used to detect cytochrome c using a monoclonal anti–cyto-
chrome c antibody (BD PharMingen).
 
Analysis of Caspase-9 Activity.
 
Macrophages were treated
with 50 
 
 
 
M LY294002 and/or 100 
 
 
 
M zVAD.fmk, as indicated,
for 48 h. Cells were harvested and suspended in 50 
 
 
 
l of lysis
buffer for 10 min. The reaction buffer and the caspase-9 substrate
Ac-LEVD-AFC were added and incubated at 37
 
 
 
C for 1 h. Fluo-
rescence was measured using a fluorometer at 400-nm excitation
and 505-nm emission as described previously (4).
 
Reverse Transcription PCR.
 
Total cellular RNA was extracted
and was used for reverse transcription as described previously (4).
The cDNA was amplified using specific glyceraldehyde 3-phos-
phate dehydrogeanse or Mcl-1, A1, and Bcl-x
 
L
 
 primer pairs, re-
spectively. We used the following sequences for the Mcl-1:
5
 
 
 
-CGGCAGTCGCTGGAGATTAT-3
 
 
 
 (526–545, sense) and
5
 
 
 
-GTGGTGGTGGTTGGTTA-3
 
 
 
 (1,062–1,081, antisense; ref-
erence 27). The sequences for A1 were: 5
 
 
 
-CAGCACATT-
GCCTCAACAGC-3
 
 
 
 and 5
 
 
 
-TGCAGATAGTCCTGAGCC-
AGC-3
 
 
 
 (28). The sequences for Bcl-x
 
L 
 
were: 5
 
 
 
-CCAG-
AAAGGATACAGCTGG-3
 
 
 
 and 5
 
 
 
-CTCCTGGATCCAAG-
GCTCTA-3
 
 
 
. The primers for GAPDH were purchased from
CLONTECH Laboratories, Inc.
 
Statistical Analysis.
 
Results were expressed as the mean 
 
  
 
SE.
Significance was determined by an unpaired two-tailed Student’s
 
t
 
 test.
 
Results
 
Akt-1 Is Constitutively Activated by PI3K in Human
Monocyte-differentiated Macrophages.
 
Earlier studies dem-
onstrated that PI3K activation and pp70
 
s6k
 
 were important
in survival of peritoneal thioglycollate elicited macrophages
(15), although the role of Akt-1 was not examined. There-
fore, unstimulated in vitro–differentiated human macro-
phages were examined to determine if Akt-1 was constitu-
tively activated. Total and active phospho-Akt-1 were
determined by Western blot analysis. Akt-1 was constitu-
tively activated in monocyte-differentiated macrophages
and the PI3K inhibitor LY294002 suppressed activation,
but not the expression of Akt-1 at 24 and 36 h (Fig. 1).
Therefore, Akt-1 was constitutively activated in normal
macrophages and its activation was mediated through the
PI3K pathway.
 
Inhibition of PI3K or Akt-1 in Macrophages Induces Cell
Death and Apoptosis of Human Monocyte-differentiated
Macrophages.
 
To characterize the mechanism of Akt-1
activation, monocyte-differentiated macrophages were
treated with varying concentrations of the PI3K inhibitor,
LY294002 (from 12 
 
 
 
m to 100 
 
 
 
m), or control medium
 
containing DMSO for 48 h. Cell death, determined by
MTT, was observed at each concentration of LY2942002
employed (Fig. 2 A). At 50 
 
 
 
M, cell death was detected at
24 h, with 
 
 
 
80% death by 48 h (Fig. 2 C). To determine if
cell death was due to inhibition of Akt-1, macrophages
were infected with an adenoviral vector expressing a DN
version of Akt-1 (AdDNAkt-1) or the control vector
(AdGFP) at concentrations ranging from 25 to 200 moi for
48 h (4, 23). Macrophage cell death was observed in a
dose-responsive fashion when cells were infected with
AdDNAkt-1 compared with AdGFP (Fig. 2 B). Again, cell
death was observed by 24 h of infection, increasing to
 
 
 
80% by 72 h (Fig. 2 D). These observations indicate that
PI3K-activated Akt-1 is essential for macrophage survival.
The mechanism of macrophage death resulting from in-
hibition of Akt-1 was examined. DNA fragmentation was
observed by 12 h, which increased over the next 24 to 48 h
after the addition of LY294002 (Fig. 3 A) or infection with
AdDNAkt-1 (Fig. 3 B). Supporting the results obtained
with LY294002, another PI3K inhibitor, Wortmannin,
also induced cell death and DNA fragmentation in human
monocyte-differentiated macrophages (data not shown).
Additionally, LY294002 and Wortmannin induced cell
death and apoptosis in murine macrophage cell line RAW
264.7 (data not shown).
The role of the mitochondria in the induction of DNA
fragmentation was also determined by examining the loss of
 
  
 
m
 
, by Rh123 retention. The loss of 
 
  
 
m
 
 was observed
as early as 12 h after the addition of LY294002 (Fig. 3 C) or
infection with the AdDNAkt-1 (Fig. 3 D). In each in-
stance, the loss of 
 
  
 
m
 
 was associated with the induction
of apoptosis, determined by DNA fragmentation (Fig. 3, A
and B). The loss of 
 
  
 
m
 
 and DNA fragmentation were de-
tected by 12 h after infection with AdDNAkt-1, where as
significant differences were first observed at 24 h after treat-
ment with LY294002.
 
Constitutively Activated Akt-1 or Bcl-x
 
L
 
 Protects Macrophages
from LY294002-induced DNA Fragmentation.
 
To deter-
mine if the apoptotic cell death induced by inhibition of
Figure 1. Akt-1 is constitutively activated in human macrophages,
which is PI3K dependent. The expression of total and activated Akt-1 was
determined by immunoblot analysis. Activated Akt-1 was detected using
an antibody specific to phospho-Akt-1 (P-Akt-1, the activated form of
Akt-1). Whole cell lysates from macrophages treated with LY294002, or
control medium (DMSO), for the indicated periods of time, were probed
for Akt-1 and P-Akt-1 by rabbit anti-total Akt-1 or phospho-Akt-1 anti-
bodies (New England Biolabs). The final concentration of LY294002
(LY) is 50   . The results shown are representative of four experiments. 
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PI3K in macrophages was specifically due to inhibition of
Akt-1 signaling, a constitutively activated form of Akt-1
(MyrAkt-1) was employed. Macrophages were infected
with replication-defective Ad expressing constitutively ac-
tivated Akt-1 (AdMyrAkt-1) or a control vector (Ad
 
 
 
gal)
for 48 h and then treated with LY294002 for an additional
48 h. Expression of MyrAkt-1 protected against loss of
 
  
 
m
 
, DNA fragmentation and cell death (PI uptake) (Fig.
4). Since the loss of   m appeared temporally to coincide
with the induction of DNA fragmentation after PI3K/Akt-1
inhibition, experiments were performed to determine if the
expression of an antiapoptotic Bcl-2 family member was
also protective. Infection of macrophages with an adeno-
viral vector expressing Bcl-xL, important in maintaining
mitochondrial integrity (29), not only protected against the
loss of   m induced by LY294002, but also against DNA
fragmentation and PI uptake (Fig. 4). These observations
indicate that in macrophages activated Akt-1 suppressed the
induction of apoptosis by protecting mitochondrial integ-
rity.
Inhibition of PI3K/Akt-1 Activation Results in Release of
Cytochrome c, Activation of the Caspase Cascade, and Cleavage
of PKC . To characterize the mechanism of the apoptosis,
the effects of PI3K/Akt-1 inhibition on cytochrome c re-
lease and caspase activation were examined. 7-d macro-
phages were treated with LY294002 or infected by AdD-
NAkt-1 for 24 h. Cytosolic cytochrome c was detected by
Western blot assay after LY294002 treatment or Akt-1 inhi-
Figure 2. Inhibition of PI3K or Akt-1 activation re-
sults in macrophage cell death in a time and dose-
dependent fashion. Macrophages were incubated with
the PI3K inhibitor LY294002 at concentrations rang-
ing from 12 to 100  M (A) or at 50  M (C). Control
medium possessed DMSO alone. Adenoviral infection
of macrophages was performed with a vector express-
ing a DN form of Akt-1 (AdDNAkt-1) or a control
vector (AdGFP; B and D). The dosage of Ad used is
presented on the abscissa in B and was 200 moi in D.
The cells were harvested at time points indicated (C
and D) or at 48 h (A and B). Survival was determined
by relative MTT values (A and B), compared with
control-treaded cells (DMSO or AdGFP), or as viable
cell number determined by counting Trypan blue neg-
ative cells (C and D). *P   0.05 determined by un-
paired Student’s t test compared with control. The re-
sults (mean   1 SE) of a single experiment, performed
in triplicate, are presented, which was representative of
three experiments.
Figure 3. Inhibition of PI3K (LY294002) or DN
Akt-1 results in the loss of   m and DNA frag-
mentation. Macrophages were incubated with the
PI3K inhibitor LY294002 (50  M) or control
DMSO (A and C) for 12–72 h, as indicated. Mac-
rophages were infected with AdDNAkt-1 or the
control vector (AdGFP or Ad gal; B and D) at 200
moi for 12–72 h. The effects on apoptosis were de-
termined by DNA fragmentation by PI staining
( 2N DNA; A and B), and on   m determined by
Rh123 retention (mean fluorescence, percentage of
control) (C and D). *P   0.05, **P   0.01 deter-
mined by unpaired Student’s t test compared with
control. The results (mean   1 SE) of a single ex-
periment, performed in triplicate, are presented,
which was representative of three experiments.117 Liu et al.
bition (Fig. 5 A). No cytochrome c oxidase subunit IV was
detected in the same cytosolic fractions (data not shown).
To further characterize the mechanism of apoptosis induced
by PI3K/Akt-1 inhibition, caspase activation was assessed.
7-d macrophages were infected with AdGFP or AdDNAkt-1
at 200 moi for 12 and 24 h. Immunoblot analyses revealed
that the proforms of caspases-9 and -3 were decreased by
24, but not 12, h after the infection of AdDNAkt-1 (Fig. 5
B). Additionally full-length PKC , which is cleaved by ac-
tive caspase-3, was reduced at 24, but not 12, h after infec-
tion with AdDNAkt-1. These observations suggest that af-
ter inhibition of the PI3K/Akt-1 pathway, the loss of   m,
and cytochrome c release result in activation of caspases-9
and -3, cleavage of PKC , and DNA fragmentation.
Caspase Inhibition Reduces DNA Fragmentation Induced by
the Inhibition of Akt-1 Activation, but Does Not Protect Mito-
chondrial Integrity or Promote Cell Survival. To further
characterize the role of caspase activation during macro-
phage apoptosis induced by PI3K/Akt-1 inhibition,
cells were cultured with either a general caspase inhibi-
tor (z-VAD.fmk) or a specific inhibitor of caspase-9
(z-LEHD.fmk) in the presence of LY294002. Treatment
with 100  M of z-VAD.fmk or z-LEHD.fmk failed to pre-
vent LY294002-induced mitochondrial dysfunction (Fig. 6
A) or cell death (PI-positive cells) (Fig. 6 C). In contrast, DNA
fragmentation was significantly decreased by the addition of
either z-VAD.fmk or z-LEHD-.fmk (Fig. 6 B). The role of
caspase activation was further characterized by examining
the effect of z-VAD.fmk, on the activation of caspases-9
and -3. Caspase 9 (Fig. 6 E) and caspase-3 activity (data not
shown) induced by inhibition of PI3K were both sup-
pressed by treatment with z-VAD.fmk. Consistent with
this observation, the cleavage of caspase-3 and PKC  (Fig.
6 E) induced by inhibition of PI3K/Akt-1 pathway was
also suppressed. These observations suggest that the loss of
  m induced by inhibition of the PI3K/Akt-1 pathway,
resulted in cell death, independent of caspase activation.
Figure 4. Overexpression of activated Akt-1 (Myr-Akt-1) and Bcl-xL
protects against the loss of   m, DNA fragmentation and PI uptake after
the inhibition of PI3K. Macrophages were infected with Ad vectors ex-
pressing activated Akt-1 (MyrAkt-1), Bcl-xL, or control  gal at 200 moi
for 48 h, then treated with LY294002 (50  m) for an additional 48 h.
The cells were collected and analyzed for mitochondrial integrity by
Rh123 retention (mean flourescence, percentage of control; A), DNA
fragmentation (%  2N DNA, B), and PI uptake (C). *P   0.05 deter-
mined by unpaired Student’s t test compared with control. The results
(mean   1 SE) of a single experiment, performed in triplicate, are pre-
sented, which was representative of three experiments.
Figure 5. Inhibition of Akt-1 in macrophages results in the release of
cytochrome c, activation of caspases-9 and -3, and cleavage of PKC .
(A). Macrophages were treated with 50  M LY294002 or infected with
AdDNAkt-1 or the control AdGFP (200 moi) for 24 h. The cells were
harvested and Western blots performed on the cytosolic fraction for cy-
tochrome c or tubulin. (B). Macrophages were infected with adenoviral
vectors expressing DN Akt-1, or the control GFP, at 200 moi for 12
and 24 h, as indicated. Cell lysates were collected and Western blot anal-
ysis performed as described in Materials and Methods using a rabbit
anti–caspase-9, rabbit anti-PKC , mouse anti-caspase-3, and mouse
anti-tubulin. The expression of the pro-form of caspases-9 and -3 and
full-length PKC  are shown. The results presented are representative of
two experiments.118 Constitutive Akt-1 Activation Is Essential for Macrophage Survival
Our previous studies have shown that cell surface Fas–
FasL interactions on human macrophages may contribute
to the induction of apoptosis after the reduction of Fas-
associated death domain–like IL-1ß–converting enzyme–
inhibitory protein (3). Activated Akt-1 may suppress the
expression of FasL, which may be mediated by phosphory-
lation of forkhead transcription factors (30). However, the
expression of Fas and FasL on the surface of macrophages,
determined by flow cytometry, was not affected by
LY294002 treatment (data not shown). Additionally, in or-
der to determine if Fas–FasL interactions may have contrib-
uted to the induction of apoptosis after the inhibition of the
PI3K/Akt-1 pathway, macrophages were pretreated with
antagonistic anti-FasL antibody for 1 h before the addition
of LY294002. The antagonistic anti-FasL antibody had no
effect on the loss of   m, DNA fragmentation, or cell
death induced by LY294002 (data not shown). Addition-
ally, TNF-  was not detected in the culture supernatants of
macrophages, even after adenoviral infection (data not
shown). These data, together with the lack of protection of
mitochondrial integrity by zVAD.fmk, suggest that death
receptor signaling was not responsible for initiating
LY294002-induced   m loss and apoptosis.
There Is No Relationship between Constitutively Activated
NF- B and Akt-1 in Normal Macrophages.  We recently
demonstrate that NF- B was constitutively activated, and
protected against apoptosis, in differentiated macrophages
(4, 23). Additionally, recent studies have demonstrated that
Akt-1 mediates the activation of NF- B in certain cell
types (21, 22, 31, 32). To characterize the potential con-
nection between the Akt-1 and NF- B activation, studies
were performed to determine if inhibition of Akt-1 activa-
tion decreased the constitutive activation of NF- B in
normal human macrophages. Macrophages were treated
Figure 6. Caspase inhibitors do not prevent the loss of   m or macrophage PI uptake af-
ter PI3K/Akt-1 inhibition. Macrophages were treated with 100  M zVAD.fmk, the
caspase-9 inhibitor z-LEHD.fmk (100  M) or control medium for 1 h, then 50  M
LY294002 was added for an additional 48 h. The cells were harvested and analyzed for mi-
tochondrial retention of Rh123 (mean fluorescence, percentage of control; A), DNA frag-
mentation (%  2N DNA, B), PI uptake (percentage of PI-positive cells, C), caspase-9 ac-
tivity (D), and the expression of proform of caspase-3 and full-length PKC  (E). Each of the
methods has been described previously. The results presented in each panel are representa-
tive of two or three experiments.119 Liu et al.
with the PI3K inhibitor LY294002 for 24 and 48 h, and
nuclear proteins were extracted for analysis by EMSA.
Neither LY294002 nor DN Akt-1 inhibited the constitu-
tive activation of NF- B in human monocyte-differenti-
ated macrophages (Fig. 7, A–C). Additionally, LY294002
did not interfere with the activation of NF- B by TNF- 
in macrophages (Fig. 7 A). To further clarify the relation-
ship between the activation of Akt-1 and NF- B, mac-
rophages were infected with an adenoviral vector express-
ing NF- B–inducing kinase (NIK; reference 33). The
ectopic expression of NIK resulted in a marked increase of
NF- B activation, determined by EMSA, but failed
to protect against apoptosis induced by treatment with
LY294002 (data not shown). Our results demonstrate that
Akt-1 did not contribute to the constitutive activation of
NF- B in macrophages determined by the nuclear translo-
cation of NF- B and that increased NF- B activation did
not protect against the apoptosis induced after he inhibi-
tion of Akt-1.
Recent studies have suggested that activated Akt-1 may
enhance the transcriptional activity of NF- B (34). There-
fore, the effect of activated Akt-1 on the transcriptional ac-
tivity of NF- B in macrophages was examined. In tran-
sient transfection assays, the ectopic expression of activated
Akt-1 (Myr Akt-1) rescued RAW 264.7 cells from apop-
tosis induced by LY294002 (data not shown). In contrast,
Myr Akt-1 failed to enhance NF- B transcriptional activ-
ity, which we previously demonstrated in these cells (4),
determined by cotransfection of a 3x B promoter-reporter
(Fig. 7 D). Furthermore, there was no enhancement of
NF- B activation by cotransfection of the plasmid-
expressing Myr Akt-1 together with one expressing the
transcriptionally active p65 subunit of NF- B (Fig. 7 D).
Further supporting the lack of effect on the transcriptional
activity of NF- B, inhibition of the PI3K/Akt-1 pathway
in macrophages, did not reduce the expression of A1/Bfl-1
by reverse transcription PCR (Fig. 9 B), which is exquis-
itely sensitive to the constitutive activation of NF- B in
macrophages (4). Together, these observations demonstrate
that in macrophages, the protection against apoptosis ob-
served with activated Akt-1 is not mediated through the
activation of NF- B.
Inhibition of PI3K/Akt-1 Has No Effect on the Expression of
Apoptosis-related Molecules Bcl-2, Bcl-xL, Bax or Bad, but Re-
sults in Inhibition of Mcl-1. Since members of the Bcl-2
family control mitochondrial integrity, the effect PI3K/
Akt-1 pathway inhibition on the expression of Bcl-2 family
members was examined. Inhibition of PI3K/Akt-1 by
Figure 7. The activation of
Akt-1 does not contribute to the
constitutive or the induced acti-
vation of NF- B in macrophages.
(A) Macrophages were washed
three times and cultured in se-
rum-free medium for 18 h. The
cells were then treated with 50
 M LY294002 or control
DMSO for 2 h. Finally macro-
phages were treated with 10 ng/
ml TNF- , 100 ng/ml LPS, or
control medium as indicated for
an additional 6 h. Nuclear ex-
tracts were harvested and EMSA
was conducted. The composi-
tion of the NF- B complex was
determined by supershift analysis
using antibodies specific for NF-
 B p65 and p50, as indicated. (B) Macrophages were infected with AdDNAkt-1 or control AdGFP and cultured in serum containing medium for another
for 24 and 48 h. (C) Treatment with LY294002 does not inhibit the constitutive activation of NF- B. Macrophages were treated with 50  M LY294002 or
control DMSO for 24 or 48 h, before harvesting. (D) The 3x B promoter-reporter plasmid (1  g) was cotransfected with plasmid-expressing activated Akt-1
(1  g MyrAkt) alone or together with a plasmid-expressing NF- B p65 (1  g) as described in Materials and Methods. The cells were harvested after 18 h,
and cell lysates were prepared to measure luciferase activity, which was determined as RLU per microgram of protein. The results are presented as fold com-
pared with cells transfected with the control plasmid (no). The results (mean   1 SE) of a single experiment, performed in triplicate, are presented, which
was representative of three experiments.120 Constitutive Akt-1 Activation Is Essential for Macrophage Survival
LY294002 did not influence the expression of antiapop-
totic molecules Bcl-2 or Bcl-xL or the proapoptotic mole-
cule Bax, as determined by Western blot analysis (Fig. 8 A).
Similar results were obtained after infection with AdD-
NAkt-1 (data not shown). Additionally, no change in the
expression of phosphorylated Bad, which may contribute
to protection of mitochondrial integrity, was observed in
response to LY294002 treatment (Fig. 8 B). Furthermore,
the expression of Bcl-xL and A1/Bfl-1 (35, 36) were not
reduced after PI3K/Akt-1 inhibition by LY294002 (Fig. 9
B). In contrast, inhibition of PI3K by treatment with
LY294002, or infection with AdDNAkt-1, suppressed
Mcl-1 expression in macrophages by 24 h (Fig. 9, A and B)
before the activation of caspase-3 (Fig. 8 A). These obser-
vations suggest that Mcl-1 may be the downstream target
of the PI3K/Akt-1 pathway responsible for protecting
macrophage mitochondrial integrity.
Mcl-1 Is Essential for Macrophage Viability. Since reduc-
tion of Mcl-1 was associated with cell death, experiments
were performed to determine if Mcl-1 protected against
cell death induced by inhibition of the PI3K/Akt-1 path-
way. These experiments were performed with RAW 264.7
murine macrophages, since inhibition of the PI3K/Akt-1
pathway induced apoptosis, by a mechanism that was the
same as observed in primary human macrophages (data not
shown). A GFP-expressing plasmid was cotransfected with
a control vector or one expressing Mcl-1. After 24 h, the
cells were treated with LY294002 or vehicle control and
cell viability was determined. Mcl-1 protected the RAW
264.7 macrophages from cell death induced by the inhibi-
tion of the PI3K/Akt-1 pathway (Fig. 9 C). These observa-
tions suggest that the constitutive activation of Akt-1 main-
tains the expression of Mcl-1, which is necessary for the
protection of mitochondrial integrity in macrophages. To
confirm that Mcl-1 was essential for macrophage viability,
7-d differentiated human macrophages were incubated
with Mcl-1 antisense or control (INV) oligonucleotides.
The reduction of Mcl-1 by the antisense resulted in macro-
phage apoptosis (Fig. 9, D and E). These observations sup-
port an essential role for Mcl-1 in protecting macrophages
from apoptosis induced by the loss of mitochondrial integ-
rity.
Discussion
Prior studies using mice deficient in src homology 2 do-
main–containing 5  inositol phosphatase or PTEN demon-
strated an expansion of their macrophage populations (9,
10). Both of these phosphatases normally function to sup-
press the PI3K pathway (11, 12), suggesting that this path-
way may be unique and critical for macrophage survival.
The potential mechanisms by which this pathway may be
important in macrophage survival have not been character-
ized. This study is the first to demonstrate that Akt-1 was
constitutively activated in human monocyte-differentiated
macrophages, and that specific inhibition of Akt-1 resulted
in apoptotic cell death mediated by the loss of mitochon-
drial integrity. To date most studies have focused on the
role of the PI3K/Akt-1 pathway in the regulation of apop-
tosis in proliferating cells rather than in terminally differen-
tiated cells, such as macrophages.
Although the mechanism responsible for the constitutive
activation of the PI3K/Akt-1 pathway in the differentiated
human macrophages was not characterized in our manu-
script, it is possible that factors present in serum may be im-
portant. Lysophosphatidic acid, M-CSF, and 1 , 25-dihy-
droxyvitamin D3, which may be present in normal serum,
are capable of activating the PI3K pathway (15, 37, 38). It
is not possible to withhold serum during monocyte to mac-
rophage differentiation, since we have shown that most
monocytes die by Fas–FasL–mediated apoptosis without se-
rum (3). However, serum deprivation for 24 to 96 h after
differentiation did not result in macrophage death (data not
shown), suggesting that the continued presence of a factor
in serum was not necessary for the survival of terminally
differentiated human macrophages. In contrast, murine
thioglycollate-elicited macrophages and bone marrow–
derived macrophages, which proliferate in culture (39),
died in the absence of serum or CSF-1 (15, 40). These ob-
servations suggest that the murine macrophages (15, 40)
may not be terminally differentiated or that the mechanism
of protection against cell death was different, perhaps due
to proliferation or activation that occurred during recruit-
ment and isolation.
Figure 8. Inhibition of PI3K/Akt-1 has no effect on the expression of
apoptosis-related molecules Bcl-2, Bcl-xL, Bax, or Bad. (A) Macrophages
were treated with LY294002 (LY) at 50  M for 24 or 48 h, as indicated.
Cell lysates were collected and Western blot analyses were conducted us-
ing mouse anti–caspase-3, mouse anti-Bcl-2, rabbit anti-Bcl-xL, mouse
anti-Bax, or mouse anti-tubulin antibodies as described in the Materials
and Methods. (B) Macrophages were treated with 50  M LY294002 for
48 h, then cell lysates was collected and immunoprecipitated using rabbit
anti-Bad antibody. Western blot analysis was performed probing the im-
munoprecipitated complex with specific rabbit anti-Bad (Bad) or rabbit
anti-phospho-Bad (P-Bad) antibodies. The result shown is one of three
experiments with similar results.121 Liu et al.
Akt-1 has been shown to promote cell survival, and pro-
tect against apoptosis, by a number of mechanisms. How-
ever, the mechanisms by which the PI3K/Akt-1 pathway
contributes to the survival of terminally differentiated mac-
rophages have not been described previously. Akt-1 activa-
tion, in certain cell types, may promote survival by protect-
ing against Fas signaling (41). Additionally, PTEN /  mice
demonstrate impaired Fas-mediated apoptosis that is re-
stored by PI3K inhibitors (10). However, our data do not
support a role for death receptor signaling after the inhibi-
tion of the PI3K/Akt-1 pathway. The broad-based caspase
inhibitor z-VAD.fmk protected against DNA fragmenta-
tion, a characteristic feature of the apoptotic phenotype,
however, it failed to protect against the loss of   m or cell
death, suggesting that activation of the initiator caspase-8
was not responsible. Additionally, we observed no change
in the expression of Fas or FasL on the cell surface, and an-
tagonistic anti-FasL antibody did not prevent the apoptosis
observed (data not shown). These observations demon-
strate that, after inhibition of the PI3K/Akt-1 pathway,
death receptor ligation and caspase-8 activation did not ini-
tiate macrophage apoptosis and cell death.
Akt-1 may regulate cell survival at a postmitochondrial
level, after the release of cytochrome c, by inhibiting the
activation or activity of caspase-9 (18, 42). In a previous
study, cytochrome c–induced activation of caspase-9 was
inhibited by either z-VAD.fmk or activated Akt-1 (42). In
macrophages, inhibition of the PI3K/Akt-1 pathway with
either LY294002 or the DN Akt-1 resulted in loss of   m
and cytochrome c release. However, caspase inhibition by
either z-VAD.fmk or a caspase-9–specific inhibitor partially
protected against DNA fragmentation, but failed to protect
against the loss of   m or cell death. These observations
demonstrate that the protection provided by constitutively
activated Akt-1, that was essential for macrophage survival,
was upstream of the loss of   m and did not require
caspase activation. Inhibition of caspase activation altered
the apoptotic phenotype (i.e., DNA fragmentation and
PKC  cleavage), but did not protect against cell death. It is
possible that mechanisms other than the loss of   m may
have contributed directly to cell death. Apoptosis-inducing
factor (AIF), when released from the mitochondria after the
loss of   m, translocates to the nucleus, inducing chroma-
tin condensation and DNA fragmentation, independent of
Figure 9. PI3K/Akt-1-regu-
lated Mcl-1 is necessary for mac-
rophage survival.  Inhibition of
PI3K/Akt-1 downregulates the
expression of Mcl-1 at the pro-
tein (A) and transcriptional (B)
levels. (A) Macrophages were
treated with 50  M LY294002
or infected with AdDNAkt-1
(200 moi) for 24 or 36 h as indi-
cated in the figure. Cell lysates
were collected and Western blots
were performed with rabbit anti-
Mcl-1 and mouse anti-tubulin
antibodies as indicated. (B) Mac-
rophages were treated with 50
 M LY294002 for 12, 24, and
36 h as indicated in the figure.
Then the total RNA was ex-
tracted and used for the synthesis
of cDNA. PCR was conducted
using primers specific for Mcl-1,
A1, Bcl-xL, and glyceralde-
hyde 3-phosphate dehydrogenase
(GAPDH), as described in Mate-
rials and Methods. (C) The ex-
pression of Mcl-1 rescues RAW
264.7 macrophage-like cells from
cell death after the inhibition of
the PI3K/Akt-1 pathway. RAW
cells were transfected with a plas-
mid-expressing enhanced GFP
(0.5   g) plus a control plasmid
(pCl-neo) or one expressing
Mcl-1 (pCl-MCL-1), each at 2.5
 g, as described in Materials and
Methods. The transfected cells
were then treated with 50  M
LY294002, where indicated, for
24 h. The cells were harvested and the number of enhanced GFP-positive cells was determined by flow cytometry. Macrophages were treated with Mcl-1
antisense oligonucleotides (AS) or control oligonucleotides (INV) for 24 h, cells were collected, and Mcl-1 expression detected by Western blot assay (D)
and apoptosis determined by DNA fragmentation ( 2N DNA; E). The results presented in each panel are representative of two or three experiments.122 Constitutive Akt-1 Activation Is Essential for Macrophage Survival
caspase activation (43, 44). Consistent with a role AIF in
cell death, z-VAD.fmk only partially protected against
DNA fragmentation, after inhibition of the PI3K/Akt-1
pathway. Therefore, the loss of   m and the subsequent
release of AIF may both have directly contributed to mac-
rophage death after inhibition of the PI3K/Akt-1 pathway.
Supporting the central role for the loss of   m in the in-
duction of cell death after the inhibition of the PI3K/Akt-1
pathway, the ectopic expression of Bcl-xL protected not
only against DNA fragmentation, but also prevented the
loss of   m and cell death, even though no reduction of
endogenous Bcl-xL or Bcl-2 was observed. Prior studies
have demonstrated that activated Akt-1 phosphorylated
Bad (17, 45), which inhibited the binding of Bad with
Bcl-xL, thereby promoting survival and protecting against
apoptosis. Although this mechanism would result in apop-
tosis and cell death initiated by loss of   m, we observed
no effect on the expression or phosphorylation of Bad in
macrophages after inhibition of PI3K/Akt-1 activity. Simi-
lar to this observation, other studies have not observed an
effect on the phosphorylation of Bad after the inhibition of
Akt-1 in fibroblasts and a neuronal cell line (19, 46). These
data suggest that, although Bad may be involved in a cell-
type and stimulus-specific fashion, it was not involved in
macrophage apoptosis observed after the inhibition of the
PI3K/Akt-1 pathway.
We recently demonstrated that the constitutive activa-
tion of NF- B was essential for the survival of macro-
phages by maintaining mitochondrial integrity (4). There-
fore, experiments were performed to determine if Akt-1
contributed to NF- B activation in macrophages, as re-
cently demonstrated in other cell types (31, 32, 34, 47). In
contrast to these observations, inhibition of the PI3K/Akt-1
pathway had no effect on the constitutive or TNF- –
stimulated activation of NF- B in macrophages, as deter-
mined by EMSA. Consistent with this observation, TNF- 
failed to induce activation of Akt-1 in monocytes (48). We
also observed no effect of Akt-1 on the transcriptional ac-
tivity of NF- B in the RAW 264.7 macrophage cell line,
in contrast to recent studies in other cell types (34, 47).
Our study directly examined the effects of Myr Akt-1 on
the constitutive and the NF- B p65 induced activation of a
NF- B promoter-reporter construct. The differences ob-
served between the studies may be due to the experimental
design or cell-type differences (34, 47). Cell-type differ-
ences may be important since Myr Akt-1 activated a  B
promoter in 3T3 cells (34), but not in RAW 264.7 macro-
phages, even though Myr Akt-1 protected the RAW 264.7
cells against cell death induced by inhibition of the PI3K
pathway.
Further supporting a mechanism independent of NF- B,
the ectopic expression of NIK, which resulted in strong ac-
tivation of NF- B in macrophages, failed to protect against
cell death induced after the inhibition of the PI3K path-
way. Also, expression of the activated form of Akt-1 in
macrophages, which protected against the apoptosis ob-
served after treatment with LY294002, failed to activate
NF- B (data not shown). Additionally, we previously
demonstrated that the antiapoptotic molecule A1 was an
important downstream target of the constitutively activated
NF- B in macrophages (4). However, after PI3K/Akt-1
inhibition, no reduction in the expression of A1/Bfl-1 was
observed. This observation is consistent with the lack of ef-
fect of PI3K/Akt-1 on the transcriptional activity of NF-
 B, since A1/Bfl-1 expression in macrophages was exquis-
itely regulated by constitutively activated NF- B (4).
These observations demonstrate that the protection pro-
vided by the constitutively activated PI3K/Akt-1 pathway
in macrophages was independent of the NF- B activation.
These observations support the independent role of A1,
regulated by constitutively activated NF- B and Mcl-1,
regulated by the PI3K/Akt-1 pathway, in maintaining mi-
tochondrial integrity, protecting against spontaneous apop-
tosis, in primary differentiated macrophages. The in-
dependence of the pathways is further supported by the
observation that the apoptosis induced by inhibition of A1/
NF- B does not result in activation of caspase-3 (4), while
that which results from inhibition of PI3K/Akt-1/Mcl-1
does result in caspase-3 activation. This suggests that multi-
ple pathways promote macrophage survival, even without
specific stimulation or stress.
Since the loss of   m induced by PI3K/Akt-1 inhibi-
tion was protected by Bcl-xL, the expression of Bcl-2 fam-
ily members was examined. Although Akt-1 regulated T
lymphocyte survival, NF- B activation and Bcl-xL expres-
sion (49), we did not detect an effect of PI3K/Akt-1 inhi-
bition on the expression of Bcl-xL consistent with other
studies (19, 46). These differences may be due to cell-type
and/or stimulus-specific differences. Also, no change in the
expression of the antiapoptotic molecules Bcl-2 or A1 or
the proapoptotic molecule Bax was observed. In contrast,
the expression of Mcl-1 mRNA and protein was reduced
after inhibition of the PI3K/Akt-1 pathway in macro-
phages. Supporting the importance of Mcl-1 in macro-
phages, Mcl-1 expression protected against the apoptotic
cell death observed in the RAW 264.7 macrophage cell
line after inhibition of the PI3K/Akt-1 pathway. Support-
ing the relevance of this observation, apoptosis induced in
this cell line was associated with loss of   m, DNA frag-
mentation, and cell death that was prevented by the ex-
pression of activated Akt-1. The essential role of Mcl-1 in
primary macrophages was further supported by the obser-
vation that reduction of Mcl-1 by antisense oligonucle-
otides resulted in macrophage apoptosis. An earlier study
demonstrated that mcl-1 was regulated the PI3K/Akt-1
pathway through a transcription factor complex containing
the cAMP response–element-binding protein (50). These
observations support an essential role for Mcl-1, mediated
by the PI3K/Akt-1 pathway, in promoting macrophage vi-
ability, by maintaining mitochondrial integrity.
Mcl-1, a Bcl-2 family member, is critical to embryonic
development since deletion of this gene resulted in periim-
plantation embryonic lethality (51). Mcl-1 has been found
to exhibit differentiation stage-specific expression in a vari-
ety of hematopoietic lineages (52). Overexpression of Mcl-1
delayed apoptosis induced by c-myc, growth factor with-123 Liu et al.
drawal, and other cytotoxic agents, and reduced the release
of cytochrome c from mitochondria (53-55). In contrast,
our data suggest that Mcl-1 expression was essential in
maintaining mitochondrial integrity in macrophages, in the
absence of an exogenous death-inducing signal. Supporting
this conclusion, mice transgenic for Mcl-1 demonstrated
prolonged viability of both mature and immature myeloid
cells (56). Additionally, antisense-mediated inhibition of
Mcl-1 resulted in apoptosis of PMA-treated U937 mono-
cytic cells (24). Overall, these observations support the im-
portance of the PI3K/Akt-1 mediated–expression of Mcl-1
in maintaining macrophage viability.
Although the mechanism by which Mcl-1 protects mac-
rophage mitochondrial integrity was not examined, in a
yeast two-hybrid analysis, Mcl-1 bound avidly to Bax (57).
Bax overexpression resulted in death by induction of mito-
chondrial permeability transition (58, 59), similar to the re-
sults observed after the inhibition of the PI3K/Akt-1 path-
way. Supporting this mechanism, reduction of Bcl-xL,
another Bcl-2 family member capable of binding to Bax,
resulted in Bax-mediated cell death (60). These observa-
tions suggest that reduction of Mcl-1 in macrophages may
lead to enhanced Bax activity, although the expression of
Bax was not altered, which resulted in cell death mediated
through the loss of mitochondrial integrity. These observa-
tions provide insights into potentially novel mechanisms to
regulate macrophage survival in conditions such as athero-
sclerosis or rheumatoid arthritis.
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